- Home
- OCEA vs EQS Comparison
OCEA vs EQS Comparison
Compare OCEA & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- EQS
- Stock Information
- Founded
- OCEA 2019
- EQS 1991
- Country
- OCEA United States
- EQS United States
- Employees
- OCEA N/A
- EQS N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- OCEA Health Care
- EQS Finance
- Exchange
- OCEA Nasdaq
- EQS Nasdaq
- Market Cap
- OCEA 20.5M
- EQS 17.0M
- IPO Year
- OCEA N/A
- EQS N/A
- Fundamental
- Price
- OCEA $0.13
- EQS $1.37
- Analyst Decision
- OCEA
- EQS
- Analyst Count
- OCEA 0
- EQS 0
- Target Price
- OCEA N/A
- EQS N/A
- AVG Volume (30 Days)
- OCEA 88.9M
- EQS 3.4K
- Earning Date
- OCEA 01-13-2025
- EQS 01-01-0001
- Dividend Yield
- OCEA N/A
- EQS N/A
- EPS Growth
- OCEA N/A
- EQS N/A
- EPS
- OCEA N/A
- EQS N/A
- Revenue
- OCEA N/A
- EQS $1,137,000.00
- Revenue This Year
- OCEA N/A
- EQS N/A
- Revenue Next Year
- OCEA N/A
- EQS N/A
- P/E Ratio
- OCEA N/A
- EQS N/A
- Revenue Growth
- OCEA N/A
- EQS 1795.00
- 52 Week Low
- OCEA $0.11
- EQS $1.01
- 52 Week High
- OCEA $7.79
- EQS $1.63
- Technical
- Relative Strength Index (RSI)
- OCEA 28.02
- EQS 58.36
- Support Level
- OCEA $0.12
- EQS $1.26
- Resistance Level
- OCEA $0.16
- EQS $1.43
- Average True Range (ATR)
- OCEA 0.04
- EQS 0.05
- MACD
- OCEA 0.01
- EQS -0.00
- Stochastic Oscillator
- OCEA 8.66
- EQS 69.29
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.